Urology Devices Market - Analysis And Forecast (2017-2025): Market Shares And Strategies Of Key Players

Urology is witnessing a shift toward less invasive treatment methods. The treatment of prostate cancer is shifting from radical prostatectomy to less intrusive alternatives such as laparoscopic surgery, robotic surgery, high intensity focused ultrasound (HIFU), and brachytherapy. Similarly, urinary stones are being managed by less invasive treatment options such as extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy over percutaneous nephrolithotomy (PCNL) and open surgery. Increasingly more patients with benign prostatic hyperplasia (BPH) are treated with laser therapy, transurethral microwave thermotherapy (TUMT), and transurethral needle ablation (TUNA) over transurethral resection of the prostate (TURP).

Obtain Report Details @http://www.transparencymarketresearch.com/urology-devices-market.html

Based on the findings of the Urologic Diseases in America (UDA) project, the U.S. population spends approximately US$ 11 Bn annually for the treatment and management of urological diseases. The global prevalence of urological conditions such as BPH and urinary incontinence, which are more common in the elderly population, is expected to rise due to the rise in aging population. Prostate cancer is the fourth most common cancer in the world accounting for about 8% of all new cancer cases, excluding non-melanoma skin cancer. In the U.S., prostate cancer is estimated to account for 10% of the 161,000 new cancer cases annually. Efforts are being undertaken in various countries to improve the awareness about urological diseases among the general population. This is achieved by promotion of prostate cancer screening and initiatives such as Urology Week initiated by the European Association of Urology. Urology has been at the forefront of adopting newer technologies to improve patient outcomes. Technologies such as minimally invasive surgery and robotic surgery have been rapidly adopted after being introduced to the urology specialty. In addition, the demand for urology devices is growing due to increase in prevalence of urological diseases and growing awareness about urological conditions.

The global urology devices market is segmented on the basis of disease type, product, and region. The disease type includes BPH, prostate cancer, urinary stones, urinary incontinence, and other urological conditions. The product segment includes urology endoscopes, such as cystoscopes, ureteroscopes, and nephroscopes, robotic surgical systems, laser systems, lithotripters, brachytherapy systems, HIFU systems, urodynamic systems, and urology consumables. The robotic surgical system is witnessing a widespread adoption in the past few years due to its clinical superiority and benefits over open procedures.

Geographically, the global urology devices market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Globally, the growth in the procedures conducted with the da Vinci robotic surgical system is being driven by urology procedures with a number of da Vinci Prostatectomies (dVP) performed outside the U.S. market, increasing from 65,000 in 2014 to 92,000 in 2016 (Source: Intuitive Surgical annual report). North America accounts for the largest share of the market followed by Europe. In Asia Pacific, the rapidly aging population in Japan and fast economic growth in China and India are factors projected to increase the demand for urology devices. The installed base of da Vinci robotic surgical system has more than doubled from 1,700 in 2010 to over 3,800 in 2016. Currently, more than 85% of prostatectomies in the U.S. are being performed through robotic surgery.

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26123

Key players operating in the global urology devices market include Olympus, Karl Storz, Stryker, Richard Wolf, Intuitive Surgical, Dornier MedTech, Lumenis, Cook Medical, Boston Scientific, CR Bard, HealthTronics, and Medtronic.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.